Abstract
The goal of treatment in allergic rhinitis (AR) is to provide effective prevention of or relief from allergic rhinitis symptoms without adversely affecting daily activities or cognitive performance. Effective treatment of allergic rhinitis usually requires an integrated regimen that combines allergen avoidance measures, pharmacotherapy and possible specific- allergen immunotherapy. Oral corticosteroids are very effective but can have unwanted systemic effects. Over the past decade, intranasal corticosteroids have been shown to be the most effective form of pharmacologic treatment for allergic rhinitis. The newer nasal corticosteroids (NCS), offers significant advantages to the patient with AR. They are superior to both antihistamines and cromones and provide topical drug delivery that targets the actions of the drug molecules to the nasal mucosa to minimize the potential for systemic side effects. However, some clinicians remain reluctant to prescribe NCS for children because of their concern for systemic effects, including suppression of growth, of bone metabolism, and of the hypothalamic-pituitary-adrenal (HPA) axis.
Keywords: Allergic rhinitis, pharmacodynamics and pharmacokinetics, nasal corticosteroid, systemic corticosteroids, adverse effects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Role of Corticosteroids in Allergic Rhinitis Treatment
Volume: 7 Issue: 1
Author(s): Murat Enoz
Affiliation:
Keywords: Allergic rhinitis, pharmacodynamics and pharmacokinetics, nasal corticosteroid, systemic corticosteroids, adverse effects
Abstract: The goal of treatment in allergic rhinitis (AR) is to provide effective prevention of or relief from allergic rhinitis symptoms without adversely affecting daily activities or cognitive performance. Effective treatment of allergic rhinitis usually requires an integrated regimen that combines allergen avoidance measures, pharmacotherapy and possible specific- allergen immunotherapy. Oral corticosteroids are very effective but can have unwanted systemic effects. Over the past decade, intranasal corticosteroids have been shown to be the most effective form of pharmacologic treatment for allergic rhinitis. The newer nasal corticosteroids (NCS), offers significant advantages to the patient with AR. They are superior to both antihistamines and cromones and provide topical drug delivery that targets the actions of the drug molecules to the nasal mucosa to minimize the potential for systemic side effects. However, some clinicians remain reluctant to prescribe NCS for children because of their concern for systemic effects, including suppression of growth, of bone metabolism, and of the hypothalamic-pituitary-adrenal (HPA) axis.
Export Options
About this article
Cite this article as:
Enoz Murat, The Role of Corticosteroids in Allergic Rhinitis Treatment, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152308783769140
DOI https://dx.doi.org/10.2174/187152308783769140 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation
Current Medicinal Chemistry The Challenges of Blood Pressure Control in Dialysis Patients
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Hemodialysis Membranes for Acute and Chronic Renal Insufficiency
Current Neurovascular Research Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Mesenchymal Stem Cells Induced In Vitro Generated Regulatory-T Cells: Potential Soldiers of Transplantation Biology
Current Biotechnology Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Current Pharmaceutical Design Role, Function and Therapeutic Potential of microRNAs in Vascular Aging
Current Vascular Pharmacology Hypertension, Diabetes and Neurodegenerative Diseases: Is there a Clinical Link through the Ca2+/cAMP Signalling Interaction?
Current Hypertension Reviews Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome
Current Vascular Pharmacology Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Editorial [Hot Topic: New Therapeutic Options in Central Nervous System Involvement of Rheumatologic Diseases (Executive Editor: Ali Gur)]
Current Pharmaceutical Design Metabolic Syndrome and Cardiometabolic Risk Factors
Current Vascular Pharmacology Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors
Current Medicinal Chemistry Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Targeting Tau Hyperphosphorylation <I>via</I> Kinase Inhibition: Strategy to Address Alzheimer's Disease
Current Topics in Medicinal Chemistry Recent Progress in Signal Transduction Research of the Angiotensin II Type-1 Receptor: Protein Kinases, Vascular Dysfunction and Structural Requirement
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Socio-economic Aspects of Alzheimer's Disease
Current Alzheimer Research